Analyst Consensus
- Current Price
- 617.11 $
- Target (Low)
- 358.00 $
- Target (Mean)
- 527.20 $
- Target (High)
- 710.00 $
- Recommendation
- Strong Buy
- Number of Analysts
- 35
Recommendation Distribution
Recommendation Distribution| Strong Buy | 4 |
|---|
| Buy | 28 |
|---|
| Hold | 6 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 1 |
|---|
Key Ratios
- Net Profit Margin
- 29.3%
- Operating Margin
- 31.9%
- Gross Margin
- 49.0%
- Return on Equity (ROE)
- 39.7%
- Return on Assets (ROA)
- 14.9%
- Revenue Growth
- 11.4%
- Earnings Growth
- 33.5%
- Debt/Equity
- 30.40
- Current Ratio
- 2.51
- Beta
- 1.67
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Jun 17, 2026 | Citigroup | Buy → Buy |
| Jun 11, 2026 | Barclays | Overweight → Overweight |
| Jun 10, 2026 | UBS | Buy → Buy |
| Jun 10, 2026 | Cantor Fitzgerald | Overweight → Overweight |
| May 28, 2026 | Cantor Fitzgerald | Overweight → Overweight |
| May 27, 2026 | Mizuho | Outperform → Outperform |